EA PHARMA CO., LTD. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-08-08

US20240262805A1

Chemistry; metallurgy

METHOD FOR PRODUCING COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

#2 | 2023-06-29 ✅ Patent 12,023,320 granted on 2024-07-02

US20230201163A1

Human necessities

Therapeutic agent for fatty liver disease

#3 | 2022-01-27

US20220022851A1

Human necessities

METHOD FOR DETERMINING LIKELIHOOD OF COLORECTAL CANCER DEVELOPMENT

#4 | 2021-12-23

US20210393159A1

Human necessities

MEDICAL SUPPORT SYSTEM

#5 | 2021-07-08

US20210206773A1

Chemistry; metallurgy

DRUG FOR TREATING DISORDERS OF CORNEAL EPITHELIUM

#6 | 2019-01-24 ✅ Patent 10,584,116 granted on 2020-03-10

US20190023699A1

Chemistry; metallurgy

Heterocyclic sulfonamide derivative and medicine containing same

#7 | 2018-09-27 ✅ Patent 10,166,234 granted on 2019-01-01

US20180271868A1

Human necessities

Pharmaceutical preparation comprising phenylalanine derivative

#8 | 2018-08-16

US20180230122A1

Chemistry; metallurgy

PRODUCTION METHOD FOR HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE, PRODUCTION INTERMEDIATE THEREOF, AND CRYSTAL

#9 | 2018-06-14

US20180162844A1

Chemistry; metallurgy

CYCLOPROPANE DERIVATIVE AND DRUG CONTAINING SAME

#10 | 2017-07-13 ✅ Patent 10,183,022 granted on 2019-01-22

US20170196870A1

Human necessities

Pharmaceutical composition for treating ulcerative colitis

#11 | 2017-06-01

US20170151200A1

Human necessities

PROPHYLACTIC OR THERAPEUTIC AGENT FOR IDIOPATHIC INFLAMMATORY MYOPATHIES

#12 | 2016-12-29

US20160376249A1

Chemistry; metallurgy

PRODUCTION METHOD FOR HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE, PRODUCTION INTERMEDIATE THEREOF, AND CRYSTAL

#13 | 2016-12-29

US20160376248A1

Chemistry; metallurgy

METHOD FOR PRODUCING HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE, AND PRODUCTION INTERMEDIATE OF SAME

#14 | 2016-11-17 ✅ Patent 10,626,112 granted on 2020-04-21

US20160332999A1

Chemistry; metallurgy

Heterocyclic sulfonamide derivative and medicine comprising same

#15 | 2016-08-25 ✅ Patent 9,822,110 granted on 2017-11-21

US20160244451A1

Chemistry; metallurgy

Sulfonamide derivative and pharmaceutical use thereof

#16 | 2016-04-14 ✅ Patent 9,561,216 granted on 2017-02-07

US20160101091A1

Human necessities

Alkylamine derivative

#17 | 2016-03-03 ✅ Patent 9,655,879 granted on 2017-05-23

US20160058734A1

Human necessities

Heteroarylcarboxylic acid ester derivative

#18 | 2015-02-19 ✅ Patent 9,533,985 granted on 2017-01-03

US20150051395A1

Chemistry; metallurgy

Sulfonamide derivative and medicinal use thereof

#19 | 2014-11-06 ✅ Patent 9,562,043 granted on 2017-02-07

US20140329796A1

Chemistry; metallurgy

Heterocyclic amide derivative and pharmaceutical product containing same

#20 | 2014-10-16 ✅ Patent 9,440,980 granted on 2016-09-13

US20140309135A1

Chemistry; metallurgy

Remedy for diabetes

#21 | 2013-11-14 ✅ Patent 10,226,400 granted on 2019-03-12

US20130304016A1

Human necessities

Multi-cell container

#22 | 2013-01-31 ✅ Patent 10,039,763 granted on 2018-08-07

US20130030013A1

Human necessities

Pharmaceutical preparation comprising phenylalanine derivative

Also check out EA Pharma Co., Ltd.'s (Tokyo, Japan) applicant profile with 13 patent applications submitted.

AssigneeID:

115649 ⎘